The Armchair Analyst
Login
Subscribe
The Armchair Analyst
Topics
Epiminder (ASX: EPI)
Epiminder (ASX: EPI)
Epiminder (ASX: EPI)
Visionflex Group (ASX:VFX)
Imugene (ASX: IMU)
Epiminder (ASX: EPI)
Saluda Medical (ASX: SLD)
IPO
Trial Results
AI
Oneview Healthcare (ASX:ONE)
Immuron (ASX: IMC)
Invion (ASX: IVX)
Immutep (ASX: IMM)
InhaleRx (ASX: IRX)
Avecho (ASX: AVE)
Dec 07, 2025
A Tale of Two IPOs: Lessons From Saluda and Epiminder’s Tough Debuts
Jason Segal
